SPDR S&P Biotech ETF $XBI Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.7% during the first quarter, Holdings Channel reports. The firm owned 819,267 shares of the exchange traded fund’s stock after purchasing an additional 21,804 shares during the quarter. Hsbc Holdings PLC’s holdings in SPDR S&P Biotech ETF were worth $65,379,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of XBI. Goldman Sachs Group Inc. grew its stake in SPDR S&P Biotech ETF by 33.0% in the first quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock valued at $1,096,866,000 after purchasing an additional 3,353,029 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of SPDR S&P Biotech ETF by 625.1% during the 1st quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after acquiring an additional 12,344,558 shares in the last quarter. BlueCrest Capital Management Ltd bought a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $138,051,000. Bessemer Group Inc. boosted its stake in SPDR S&P Biotech ETF by 4.0% during the 1st quarter. Bessemer Group Inc. now owns 1,432,066 shares of the exchange traded fund’s stock valued at $116,141,000 after purchasing an additional 55,232 shares during the period. Finally, RA Capital Management L.P. bought a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $110,615,000.

SPDR S&P Biotech ETF Stock Up 0.8%

SPDR S&P Biotech ETF stock opened at $89.92 on Friday. The business has a 50 day moving average price of $85.98 and a two-hundred day moving average price of $83.94. The stock has a market cap of $4.90 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.